What is the ticker symbol for Cerecor?

Cerecor trades under the ticker CERC on NASDAQ.

What sector does Cerecor operate in?

Cerecor is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze CERC in a portfolio?

PortView shows CERC's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Cerecor (CERC) Stock Analysis

NASDAQHealthcareBiotechnology

$2.93-1.68%

52-week range$2.93

$1.98$4.50

What Cerecor does

Cerecor Inc. operates as a biopharmaceutical firm dedicated to the discovery and marketing of therapeutic solutions, primarily addressing rare pediatric and orphan diseases. The company maintains an active pipeline, including: Inherited Metabolic Disorders: Advancing CERC-801 and CERC-802, both of which have successfully completed Phase I clinical trials, alongside CERC-803. Autoimmune Inflammatory Conditions: Developing CERC-007, an anti-IL-18 monoclonal antibody, designed to combat ailments such as adult-onset Still's disease and multiple myeloma. Complex Lymphatic Malformations: Progressing CERC-006, a dual mTOR inhibitor. Pediatric-onset Crohn's Disease: Working on CERC-002, an anti-LIGHT monoclonal antibody. Mitochondrial Disorders: Investigating CERC-913, a protide nucleotide. Rare Auto-inflammatory Diseases: Developing CERC-005, a monoclonal antibody. Symptomatic Orthostatic Hypotension: Pursuing CERC-301. Parkinson's Disease: Researching CERC-406. Beyond its research and development efforts, Cerecor also markets Millipred, an oral prednisolone formulation used to manage various inflammatory ailments. These include conditions affecting the joints (arthritis), blood, immune system, skin, eyes, respiratory system, as well as certain cancers and severe allergies. Established in 2011, when it rebranded from Ceregen Corporation to Cerecor Inc., the company's headquarters are situated in Rockville, Maryland.

Key metrics

Market cap

$38.63M

P/E (TTM)

-3.38

EPS (TTM)

$-0.87

Beta

1.44

Dividend yield

0.00%

Revenue / share

$-0.00

50-day avg

$2.87

200-day avg

$3.04

52-week high

$4.50

52-week low

$1.98

CEO

Michael Cola

ETFs linked to CERC

Broad-market and Healthcare sector ETFs an investor holding Cerecor is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how CERC fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze CERC in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Cerecor?: Cerecor trades under the ticker CERC on NASDAQ.
Which exchange is CERC listed on?: CERC is listed on NASDAQ.
What sector does Cerecor operate in?: Cerecor is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze CERC in a portfolio?: PortView shows CERC's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.